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Abstract
Eyes are said to be the windows of body, by which this beautiful world is visualized. Hu‐
man eye has a unique structure and is vulnerable to numerous infections. Whenever ana‐
tomical structures are breached, host defenses come into play, but if infection is severe
and not treated timely, it could lead to visual impairment or blindness. Parasitic infec‐
tions are considered, the significant causes of ophthalmic diseases worldwide. In this
chapter, an overview of ocular parasitic infections (OPI) is detailed out, with an initial
brief introduction followed by description of anatomy of the human eye and various de‐
fense mechanisms to provide better understanding of the parasitic infections affecting
different parts of human eye. The last part includes individual details of various human
ocular parasitic infections.
Ocular infections can be classified based on either the etiological agent or according to the
anatomical site of infection. The parasitic etiological agents include mainly protozoa, hel‐
minths and ectoparasites. Due to the complex life cycles of parasites and their tendency
to cause wide range of pathologic lesions, different parasites/parasitic infections have
been addressed separately, including brief epidemiology, clinical features, diagnosis and
treatment.
Keywords: Eye, parasitic infections, protozoa, nematodes, cestodes, trematodes, ectopar‐
asites
1. Introduction
The ocular parasitic infections (OPI) are considered significant causes of ocular pathologies
worldwide [1]. The common protozoal parasites primarily infecting the ocular tissue(s) are
Acanthamoeba species and Toxoplasma gondii [2–7]. In addition, case studies of eye diseases
caused by Leishmania, Trypanosoma cruzi, Entamoeba histolytica, Hartmannella, Plasmodium
falciparum, Microsporidia and Giardia lamblia have been rarely reported [1, 8, 9]. Among the
helminths, ocular infections are caused primarily by nematode parasites (Onchocerca volvulus,
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Loa loa, Toxocara canis and Toxocara cati) [1, 8, 10–12]. In addition, case studies of ocular infections
caused by other nematodes (Angiostrongylus cantonensis, Dirofilaria repens, Trichinella spiralis,
Thelazia callipaeda, Baylisascaris procyonis, Wuchereria bancrofti and B. malayi), cestodes (T.soli‐
um cysticercus, Echinococcus granulosus, and Multiceps multiceps larvae) and trematodes (Fasciola
hepatica and Schistosoma species) have been reported from different geographical areas [1, 8,
13–15]. The ectoparasites infecting the eye include larvae of flies [16] (Oestrus ovis, Rhinoestrus
purpureus, Dermatobia hominis, Chrysomia bezziana, Lucilia spp., Cuterebra, Hypoderma, Cochlio‐
myia, Wohlfahrtia, Gastrophilus), Phthirus pubis, hard and soft ticks (belonging to class Arach‐
nida) [1, 17]. Ocular pentastomiasis caused by the larval stage of Pentastomida, the crustacean-
related parasites, is reported to cause permanent loss of vision due to the retinal detachment
or lens subluxation [18]. Further, with the advent of HIV/AIDS (human immunodeficiency
virus/acquired immune deficiency syndrome), few ocular infections have also been reported
in HIV-infected patients [19, 20].
Ocular parasitic infections have been widely reported from different geographical areas (Table
1), mainly depending on the endemicity of the parasite(s). The prevalence depends primarily
on the geographical distribution of the parasite, socioeconomic environment and immune
status of the patient. The common modes of infection are direct contact (blepharoconjunctivitis
caused by Leishmania, Acanthamoeba keratitis, microsporidial infections, infestation caused by
lice and mites) [21–23], through blood stream (Toxoplasma chorioretinitis, retinal involvement
in malaria, uveitis caused by Toxocara) [1, 23, 24], congenital transmission (Toxoplasmosis) and
zoonotic transmission (primarily infectious diseases of animals that can naturally be trans‐
mitted to humans) [25]. In addition, few of the helminths that may lead to ocular infection are
transmitted by vectors (onchocerciasis, dirofilariasis and thelaziasis), consumption of conta‐
minated food (sparganosis, trichinellosis) and indirectly from the environment (fascioliasis,
ascariasis and echinococcosis).
Adult and/or larval stages of the parasites may reside in human ocular tissues externally or in
the ocular globe. The clinical symptoms and signs vary, depending on the etiological agent
and the ocular tissue/part involved. However, local defense mechanisms and host immune
responses play role in establishing the infection. The pathology in the eye can occur due to
direct damage by the infecting pathogen, indirectly by toxic products, immune mediated or
ectopic localization by ectoparasites. The clinical diagnosis usually mimics other pathologies
due to numerous etiologies both infectious and non-infectious, which can cause conjunctivitis,
keratitis, uveitis and endopthalmitis [26]. Thus, a high index of clinician suspicion is required
for infective parasite etiology in patients having inflammation in the eye. In addition, eye can
be involved in various systemic disorders and thorough ocular examination along with history
of travel to the endemic area, risk factors and other associated medical illness that help in
establishing the preliminary diagnosis. However, confirmatory diagnosis is usually achieved
by direct demonstration of parasite in clinical samples and/or pathological changes observed
by either slit lamp or biopsy examination [1, 8, 27, 28]. The antigen and antibody detection in
ocular fluids and/or serum usually substantiates the clinical diagnosis in few parasitic
infections (Toxoplasmosis, malaria, leishmaniasis, ocular gnathostomiasis, cysticercosis,
toxocariasis, echinococcosis) [1, 10, 29, 30]. Molecular techniques including detection of
parasite DNA by polymerase chain reaction (PCR) have added new dimensions in the
diagnosis and species identification [31–36]. The treatment of choice is mostly surgical excision,
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while in few infections, medical treatment is usually advised either in conjunction with surgical
procedure (onchocerciasis, dirofilariasis [37], cysticercosis [38], echinococcosis [39], myiasis,
infections due to ticks and mites) or for inoperable patients. Although surgical excision is
usually reserved for worms that are large, it is also recommended for space-occupying lesions
of the orbit. Drug resistance is posing problem for the effective medical treatment, thus
necessitating the discovery of new antiparasitic drugs [32]. Prevention and control measures
differ in various infections and usually include proper health education and awareness of
various risk factors. The various experimental animal models for few of the ocular infections
have been successfully established to study the pathogenic mechanisms, drug efficacy and
local immune responses [40, 41].
Although issues mainly are the timely diagnosis and treatment, yet many challenges need to
be considered/addressed.
2. Anatomy
Diagrammatic representation of human eye depicting significant ocular parasitic infections is
shown in Figure 1.
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Figure 1. Human eye anatomy depicting significant ocular parasitic infections.
2.1. Orbits
The eye balls along with extraocular muscles, nerves, blood vessels and fat are situated in the
bony cavities known as orbits. The periosteal covering of the bony orbit fuses with orbital
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septum and duramater. Abscess due to infectious agent can localize in the space beneath the
periostium. The paranasal sinuses are separated from it by the floor, medial wall and roof of
the orbit and may act as the source of orbital infection. Lamina papyracea are the thinnest bony
walls, which separate orbit from ethmoidal sinuses. Thus, any breach in it causes the ingress
of sinus microbiota to orbital tissue leading to infection. Orbital cellulitis can also be caused
by direct extension of the infection from the ethmoidal sinuses to the orbital cavity. The lateral
wall of the sphenoidal sinus constitutes the medial wall of the optic canal and infection of the
former can percolate to the latter causing optic nerve damage and visual loss. There are various
apertures present in the orbital cavity, which provides the route of communication with the
adjacent structures. The superior and inferior orbital fissures, the lacrimal fossa, nasolacrimal
duct and the optic canal constitute such important apertures [1, 42–46].
2.2. Blood supply
The ophthalmic artery and its branches constitute main arterial supply of orbit. The majority
of the venous drainage occurs through superior ophthalmic vein, which drains into cavernous
sinus that is located just posterior to the orbital apex. Veins from the facial region and many
anterior ophthalmic veins anastomose and drain into cavernous sinus through superior orbital
vein. Thus, cavernous sinus is prone to infection from facial region and also from the orbital
region through the superior ophthalmic vein leading to a serious complication.
2.3. Eyelids
The eyelids impart two protective anatomical barriers, i.e., orbital septum and conjunctiva.
Former divides the orbit from the eyelid into preseptal and postseptal spaces and provides a
physical barrier to infectious agents and latter one is reflected back on itself, which provides
protection by hindering the free movement of the material posteriorly from the anterior surface
of the globe.
2.4. Lacrimal system
Lacrimal system consists of lacrimal gland, accessory gland and excretory system. Tears are
secreted by lacrimal gland, which flows over the cornea and finally drain into nasal cavity by
nasolacrimal duct through lacrimal sac. Any obstruction to the nasolacrimal duct can lead to
regurgitation of the accumulated fluid onto the ocular surface leading to increased chances of
infection.
2.5. Layers of eye ball
The basic structure of eye ball or globe consists of three concentric layers. The outermost
covering is composed of sclera and cornea. The middle covering is composed of uveal tract,
consisting of choroid, ciliary body and iris. The inner most covering is retina. The sclera is
almost avascular except for the presence of superficial small blood vessels. The choroid is a
highly vascular structure and provides nutrition and oxygenation to the retina beneath it. Due
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to these qualities, choroid serves as a fertile area for the proliferation of various pathogens,
which spread by hematogenous route.
2.6. Anterior and posterior chambers
Anterior segment of the eye in front of the vitreous humor comprises anterior one-third of the
eye and is further divided into anterior chamber and posterior chamber. Anterior chamber is
the space between posterior surface of cornea and the iris, whereas posterior chamber is the
space between iris and the front of vitreous. The aqueous humor is produced by non-pig‐
mented ciliary epithelium in the posterior chamber and drains through the pupillary aperture
into the anterior chamber. Cornea is composed of well-organized collagen fibrils, which is
avascular in nature. Lens is also an avascular crystalline structure, which continues to grow
throughout life. Thus, aqueous humor fills these spaces and provides nutrition to the sur‐
rounding structures.
2.7. Vitreous humor
It is a gel-like substance present in front of retina and posterior to the lens in the posterior
segment of the eye. It is optically clear and is composed of collagen framework interspersed
with hyaluronic acid. During intraocular inflammation, it becomes hazy and may cause
impairment of vision.
2.8. Retina and optic nerve
Retina constitutes the innermost covering of the eye ball and captures the light energy with
the help of rods and cones. The outer half of the retina is supplied by central retinal artery,
whereas inner half receives its blood supply from the choroid.
The optic nerve is formed by axons of the inner cell layer that exits the globe. It is covered by
all the three meningeal coverings, which are direct extensions of the brain coverings. Thus, it
is vulnerable to infections originating from both within cranial vault and within orbits.
3. Ocular defense mechanisms
The surface of the eye is well protected by both mechanical and immunological defense
mechanisms. To breach the defense mechanism, some form of trauma is essential. The eyelids
provide mechanical protection to the surface of eyeball. The eyelashes protect against airborne
particles and trauma by initiating blink reflex. The cornea is also sensitive to tactile sensation
and helps in the initiation of blink reflex, which is provided by dense sensory nerve endings.
The lids direct the tears, particulate debris, allergens and microbes to the lacrimal excretory
system by its sweeping action over the anterior surface of the eyeball. Bell’s phenomenon also
provides protection to cornea as globe is turned upwards and slightly outwards during eyelid
closure to avoid corneal exposure [47]. Meibomian glands secrete lipids, which provide
stability to the tear film. The epithelial surface of the cornea and conjunctiva provides ana‐
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tomical barrier to the pathogens. This function is further strengthened by the impermeability
provided by the basement and cellular junctional complexes of the cornea. Indigenous flora
of the eye also provides protection by creating a competition for colonization by the pathogens.
Immune defense mechanisms are provided by the vascular supply of the eye. Any breach in
the anatomical defense system initiates the ocular inflammatory response, which helps in
vasodilation and exudation of immunologically active substances and cells [1, 8, 48–52].
3.1. Defenses of the tear film
There are three layers of the tear film: oil, aqueous and mucous. Majority of the tear film is
composed of aqueous layer and pH of the tear film helps in neutralization of toxic substances.
Flow of tears help in mechanical flushing of the foreign particles and allergens into the lacrimal
excretory system. Mucosal layer helps in entrapment of pathogens. Tear film contains various
immunological active substances such as lactoferrin, lysozyme, β-lysin, ceruloplasmin,
complement and immunoglobulins.
3.2. Conjunctival defenses
The conjunctival associated lymphoid tissue lies beneath the conjunctiva. It consists of both B
and T lymphocytes. B and T cell precursors mature when exposed to foreign particles or
allergens, then migrate to regional lymph nodes for further development, and thereafter return
to the conjunctiva through blood stream to produce specific immunoglobulins and cellular
defense responses.
3.3. Corneal defenses
Although the cornea is avascular, it is provided by limited defense mechanisms in the form of
Langerhans cells (dendritic cells) and immunoglobulins. The surface of the cornea is covered
by mucous glycoprotein, which helps in cross-linkage of the IgA and protects the anterior
surface of the cornea. Immune defense mechanisms are activated whenever injury occurs,
leading to recruitment of the polymorphonuclear cells, lymphocytes and fibroblasts.
3.4. Cellular immune responses
Langerhans cells are situated along the peripheral margin of the cornea and conjunctiva. These
cells possess receptors, which help in phagocytosis and processing of certain antigens for
presentation. Langerhans cells stimulate B and T cells to elicit a strong cellular immune
response. During inflammation Langerhans cells migrate toward the cornea, causing increased
release of inflammatory substances.
3.5. Leukocyte defense
Polymorphonuclear leukocytes are the hallmark of acute inflammation and are associated with
oxygen-dependent pathways for the generation of free radicals that help in killing of the
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invading pathogens. Another immune defense mechanism operated by the production of
defensins is antimicrobial proteins active against wide range of pathogens.
3.6. Defensins
Ocular surface is constantly exposed to environment and foreign bodies, thus there are greater
chances of infection. However, robust innate immune system at ocular surface protects the eye
from infection. There are several peptides of defensins and cathelicidin families that are present
in tear film and secreted by corneal and conjunctival cells. These are not only antimicrobial in
nature but also help in the recruitment of immune cells and thus provide a link to adaptive
immunity. The important defensins present in human eye are hBD-1 (human beta defensins),
hBD-2, hBD-3, CAP37 (Cathelicidin-related antimicrobial peptide), LL37 (type of cathelicidin)
and HNP-1, 2, 3 (human neutrophil defensins) [53].
4. Protozoan eye infections
4.1. Toxoplasmosis
Toxoplasmosis is caused by obligatory intracellular protozoan parasite known as Toxoplasma
gondii. The mode of infection is either by the ingestion of oocysts shed in feces of the cats or
other Felidae (definitive host) or by the consumption of tissue cyst present in the raw or
uncooked meat. Life cycle of Toxoplasma includes three stages that are oocysts, tachyzoites and
bradyzoites. It completes its life cycle in two phases, one as an intestinal phase in its homolo‐
gous host, such as cats and another as an extraintestinal phase in its heterologous host, such
as mouse, man and other animals. When cats feed on mouse brain containing tissue cysts of
T. gondii, a large number of oocysts are released in the infected cat’s feces. After 1–5 days,
oocysts get matured and become infective to man and other animals. After ingestion, oocysts
liberate sporozoites, which penetrate intestinal mucosa and reach to distant organs such as
brain, eyes, liver, spleen, lymph nodes, heart, skeletal muscles and placenta by blood and
lymphatic stream. Toxoplasma tissue cysts also occur in the skeletal muscles of the intermediate
host such as sheep and pigs (Figure 2) [54]. In addition, developing fetus can acquire the
infection transplacentally from the mother during pregnancy. Rarely, infection may also result
from consumption of drinking water contaminated with oocysts. The ocular infection can be
either congenital or acquired.
Approximately, one-third of the world’s population is thought to be infected by T. gondii. It is
common in hot and humid climates such as Central America, Asia and the Caribbean region
(Table 1, Figure 3). In Europe, toxoplasmosis is common and the highest prevalence rates have
been reported in France. Various risk factors such as geographical region, meat consumption,
personal habits, animal reservoir and climatic conditions play a significant role in the trans‐
mission of infection. In recent years, due to indoor keeping of livestock and improvement in
hygiene standards, the risk of acquiring infection has decreased tremendously in the devel‐
oped nations. However, in the developing nations, risk has increased due to population
growth, urbanization trends and increase in meat consumption. Drinking water, seawater and
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seafood contaminated with oocysts when consumed may account for many unreported cases.
Therefore, exact prevalence would be much higher than reported in the literature [55–58].
Figure 2. Life cycle of T. gondii (Diagrammatic representation).
Toxoplasmosis; AĐĂŶƚŚĂŵŽĞďĂ͘ŬĞƌĂƚŝƚŝƐ; Chagasdisease; Malaria; Leishmaniasis; Giardiasis.
Figure 3. World map showing geographical areas endemic for ocular protozoal infections.
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Ocular toxoplasmosis usually manifests in immunocompromised T. gondii-infected individu‐
als and in neonates who acquire infection transplacentally [4]. The main target organs in
congenital toxoplasmosis are the brain, eyes and placenta. T. gondii disseminates through the
blood stream, lodges at particular site(s) and develops into tissue cysts. The dendritic cells and
macrophages act as “Trojan horses” to guide the parasite through blood-brain barrier to reach
at its target site in brain [59]. Inside the host cell, it protects itself from the toxic host molecules
by hiding inside the parasitophorous vacuole (structure produced by apicomplexan parasites
that allows the parasite to develop inside host cell and protects from phagolysosomes). There
are three main clonal lineages of T. gondii. Type I strains being the highest virulent, whereas
types II and III are moderately virulent. However, at present more than 130 “atypical”
genotypes are known, but their exact role in pathogenesis is not well established. Host genetic
factors such as polymorphism in Toll-like receptors (TLR) (TLR2, 5 and 9) are also known to
play a role in the susceptibility to and severity of ocular toxoplasmosis [60, 61].
Congenital ocular toxoplasmosis usually involves both the eyes, whereas acquired ocular
toxoplasmosis is usually unilateral [62, 63]. Chorioretinitis is caused by necrotizing inflam‐
mation due to the rupture of an older cyst. Intense form of choriretinitis may occur in newborns
and patients infected with HIV. In addition, congenital toxoplasmosis patients may present
with wide range of ocular symptoms such as strabismus, nystagmus and blindness. Acute,
acquired infection may result in photophobia, scotoma and loss of central vision. Ptosis may
occur due to oculomotor nerve involvement.
Diagnosis of ocular toxoplasmosis in children with congenital infection is established by
recognizing distinctive clinical findings such as focal necrotizing retinitis, vitritis, anterior
uveitis and cataract [64] However, in cases with atypical presentation or having severe
fulminant disease, diagnosis is usually established by analyzing the intraocular fluid for the
presence of specific antibodies or the presence of parasite DNA by molecular techniques such
as PCR or real-time PCR [65, 66]. PCR is performed by targeting the Toxoplasma B1 gene or
other multiple repeat sequences [67–69]. Though, in general, PCR with amniotic fluid is known
to have significantly high sensitivity (64%) and specificity (100%) for the diagnosis of toxo‐
plasmosis [70], sensitivity of only 53 and 83% has been documented for the diagnosis of ocular
toxoplasmosis [71]. PCR can be performed on either aqueous humor or vitreous fluid, but
aqueous humor can be collected more easily. However, the DNA burden in aqueous humor
is low, and in rare instances a confirmation would necessitate vitreous sampling [72].
Antibody detection in serum samples is widely used for establishing the diagnosis of toxo‐
plasmosis [73–76], while its role is limited in establishing the diagnosis of the ocular toxoplas‐
mosis. A rising titer of specific IgG over a period of 3 weeks helps in establishing the diagnosis
[77]. The detection of specific antibodies in intraocular fluids by the enzyme-linked immuno‐
sorbent assay (ELISA) is the most commonly used test for the diagnosis of toxoplasmosis. The
Goldmann-Witmer coefficient (GWC) calculation is a common method to estimate the local
versus systemic Toxoplasma-specific IgG. This index helps in measuring the intraocular levels
of specific antibodies against Toxoplasma. It is expressed as the level of Toxoplasma-specific IgG
relative to the level of total IgG in the aqueous humor as a fraction of the level of Toxoplasma-
specific IgG relative to the level of the total IgG in the serum. A value of 2 or above is considered
as an evidence of intraocular infection. Toxoplasma specific IgG antibodies are produced in
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response to the actively multiplying tachyzoites at local site of infection [72, 78] The presence
of T. gondii-specific IgM is the hallmark of a recently acquired systemic or, possibly, ocular
infection. However, high rate of false-positive results due to the persistence of antibodies,
decreases its utility as a diagnostic marker for recent ocular toxoplasmosis. In patients with
reactivated ocular toxoplasmosis, it is not useful as T. gondii-specific IgM antibodies are either
absent or present in very low quantity [79]. Saliva samples have also been tested for the
detection of specific antibodies for the diagnosis of toxoplasma encephalitis in immunocom‐
promised individuals, but it may play a limited role in ocular toxoplasmosis [74].
An algorithm for the laboratory confirmation of clinically suspected cases of ocular toxoplas‐
mosis has been reported [72]. Reactivated form of ocular toxoplasmosis is considered in
patients with typical lesions of toxoplasmic retinochoroiditis, specific IgG seropositive, specific
IgM seronegative and responding to anti-Toxoplasma treatment. However, if patients are
specific IgM seropositive, then additional laboratory tests are required. If doubt persists about
diagnosis, paired serum and aqueous samples are required to be tested in parallel. The clinical
diagnosis along with laboratory evidence is documented in 60-85% of cases and thus, labora‐
tory evidence is lacking in 15-40% of clinically suspected patients. Analysis of aqueous humor
is useful in patients presenting with atypical ocular lesions or not responding to specific
treatment [72].
In immunocompetent individuals, toxoplasma retinochoroiditis usually resolves within 2–3
months [80]. Classic therapy or triple therapy with a combination of pyrimethamine, sulfa‐
diazine and systemic corticosteroids is recommended for lesions involving or near to fovea,
an area critical for vision. Classic therapy is usually associated with significant side effects,
therefore other drugs such as trimethoprim-sulfamethoxazole, clindamycin, atovaquone and
azithromycin are being evaluated for the treatment of ocular toxoplasmosis [81].
Trimethoprim-sulfamethoxazole (Bactrim) appears to be a safe and effective substitute for
sulfadiazine, pyrimethamine and folinic acid for the treatment of ocular toxoplasmosis.
Progressive and recurring necrotizing retinitis, with vision-threatening complications such as
retinal detachment, choroidal neovascularization and glaucoma, may occur at any time during
the clinical course if the infection is not treated on time. Congenital toxoplasmosis can lead to
cataract. The aim of the treatment is to arrest parasite multiplication during the active period
of retinochoroiditis and to minimize damage to the retina and optic disc [64].
Animal model(s) can be used to study various aspects of ocular toxoplasmosis [40].
4.2. Acanthamoeba keratitis
Acanthamoeba keratitis (AK) is caused by Acanthamoeba spp., a free-living protest parasite [82].
The word “acanth” in Greek means “spikes” and has been added as a prefix to “amoeba” to
denote the spine-like structures present on its surface. The parasite is present ubiquitously in
the environment and exists in two forms, trophozoite and cyst forms. In humans, it can enter
through eye, nasal passage or ulcerated broken skin (Figure 4). Infection of the eye can cause
blinding keratitis and life-threatening granulomatous encephalitis. Various risk factors
contributing to the development of AK are (1) wearing of contact lenses for long time, (2) poor
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personal hygiene, (3) cleaning of lenses with contaminated water and (4) formation of biofilm
on contact lenses [82].
Figure 4. Life cycle of Acanthamoeba (Diagrammatic representation).
Acanthamoeba keratitis is common among the contact lens users, and its geographic distribution
is depicted in Table 1 and Figure 3. However, in India the infection is reported even in non-
contact lens users [7]. The incidence of Acanthamoeba keratitis in developed nations varies from
1 to 33 cases per million contact lens wearers. In developing nations where contact lens users
are limited, the other suggested risk factors are trauma, exposure to contaminated water, use
of traditional eye medicine, low socioeconomic background, splashing contaminated water
into the eye following dust fall and corneal injury with mud [7, 22, 83]. The pathogenesis of
Acanthamoeba involves following sequential events, i.e., breach in the epithelial barrier,
invasion of stroma by amoeba, depletion of keratocytes, induction of inflammatory response,
photophobia and finally necrosis of stroma leading to blindness [82].
The diagnosis of AK is difficult as it is usually confused with symptoms of bacterial, fungal or
viral keratitis. However, history of contact lens use together with a history of excruciating pain
is a strong indication toward the diagnosis of AK. For establishing the clinical diagnosis with
high sensitivity, in vivo confocal microscopy can be used, which is a non-invasive procedure.
The Acanthamoeba cysts appear as hyper-reflective, spherical structures that are well defined
because of their double wall. However, trophozoites are difficult to distinguish from leuko‐
cytes and keratocyte nuclei [84, 85]. Laboratory confirmation is established by direct demon‐
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stration of parasite by immunofluorescence microscopy or by isolating the parasite in culture.
Although culture remains the gold standard, it is tedious and time consuming. Multiplex real-
Ocular protozoal infections Geographical distribution
Toxoplasmosis Worldwide particularly in Central America, Asia, Caribbean region, Europeparticularly in France
Acanthamoeba keratitis Worldwide significantly in Chicago, San Francisco, Boston, Philadelphia,Sweden, Portland, New Zealand, United Kingdom, India, Africa
Chagas disease Central and South America
Malaria Africa, Central & South America, Middle East and Asia
Leishmaniasis Africa, Mediterranean region, Middle East, Central and South America, partsof Asia
Microsporidiosis Worldwide
Giardiasis Southeast Asia, South Africa, Europe and USA
Ocular nematode infections
Onchocerciasis Africa, South America, Arabian peninsula
Loiasis Central and West Africa
Dirofilariasis Asia, Africa and Europe
Gnathostomiasis South East Asia particularly Thailand, China, Japan and India, Central andSouth America particularly in Mexico, Guatemala, Peru and Ecuador
Thelaziasis Asia Pacific region - China, India, Thailand, Indonesia, Japan and Korea
Toxocariasis Worldwide particularly in Asia, Japan, Korea, Ireland, Alabama
Ocular cestode infections
Cysticercosis Indian subcontinent, Central and South America, Africa and Far East
Echinococcosis South America, Middle East, Mediterranean countries, India and Australia
Ocular trematode infections
Fascioliasis France, Spain, Italy, Austria, Belgium, United Kingdom, Algeria, Tunisia, Iran,Uzbekistan, Korea, China, Argentina, Chile, Peru, Brazil, Guatemala
Schistosomiasis Sub-Saharan Africa, China, South Asia
Philopthalmosis Europe (Yugoslavia), Israel, Asia (Thailand, India, Sri Lanka, Japan) andAmerica (i.e., Mexico, and the United States)
Clinostomum lacramalitis Thailand
Fascioliasis Iran
Alaria mesocercariasis San Francisco, California
Ocular infections by ectoparasites
Myiasis Worldwide with greater abundance in poor socioeconomic regions of tropicaland subtropical countries, Mediterranean basin and Middle East
Phthiriasis palpebrum
Case reports from Tunisia, Taiwan, India, Pakistan, China, Korea, Lebanon,
Israel, Brazil, Turkey, United Kingdom, Belgium, Italy, Cyprus, United States
of America (USA)
Tick infestation Case reports from Ireland, Turkey and USA
Table 1. Ocular parasitic infections and geographical distribution
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time PCR assays (multiplex assays targets more than one region and simultaneously can detect
two or more target regions) have also been developed for the detection of different pathogenic
free-living amoeba and/or different genotypes of Acanthamoeba. Although molecular techni‐
ques have high sensitivity and specificity, these are only available at apex laboratories and also
require a well-established molecular laboratory [86]. Newer techniques such as Matrix-
Assisted Laser Desorption Ionization Time-Of-Flight (MALDI-TOF) and 1H-NMR spectrosco‐
py [87] are also being tested for the rapid identification of Acanthamoeba in the clinical
specimens [88].
Chances of recovery are good if the pathogen is restricted to cornea epithelium but can lead
to vision loss, if it invades stroma leading to necrosis and intense inflammation. Medical
treatment, if started early, can lead to a significant improvement within 2–3 weeks [89].
Preventive measures include thorough and adequate disinfection of contact lenses. It is
recommended to remove contact lenses before any activity involving contact with water,
including showering, using a hot tub, or swimming. Hands should be washed with soap and
water and dried before handling contact lenses. Contact lenses should not be rinsed with tap
water and should be cleaned and stored as per manufacturer’s guidelines. It is suggested that
the increased awareness about the other predisposing factors (corneal injury, fall of foreign
body in eye) among the general public may enable early and frequent recognition and proper
management of AK in patients other than contact lens wearers [7].
4.3. Chagas disease
Chagas disease or American trypanosomiasis is caused by Trypanosoma cruzi [90]. It is a chronic
systemic disease, included in the WHO’s list of most neglected tropical diseases. Approxi‐
mately, 8 million people are known to be affected in Latin America (Table 1, Figure 3) [8]. The
life cycle of the parasite is passed in two stages involving trypomastigotes and amastigotes
forms as depicted briefly in Figure 5. T. cruzi passes its life cycle in two hosts: one in man or
the reservoir host and other in the transmitting insect. The infection is transmitted by the blood-
sucking triatomine bugs when infective metacyclic trypomastigotes in bug’s feces are released
onto the skin of humans. These infective trypomastigotes enter the human host when bite
wound is either scratched or rubbed, or through permissive mucosal or conjunctival surfaces.
Parasites circulate in the human body affecting various tissues and organs. If the initial bite of
the triatomine bug is near the orbit, it may lead to severe palpebral and periorbital edema
(Romana’s sign) [91]. It causes a painless edema and constitutional symptoms of fever, malaise
and anorexia are common. Ocular involvement (posterior uveitis) in congenital Chagas disease
is recently reported. Although ocular fundus examination has been unobtrusive, small
parafoveolar retinal pigment epithelium defects have been reported in 7.6% of chagasic
patients [92].
The diagnosis of acute Chagas disease is established by the direct demonstration of trypo‐
mastigotes in the blood/buffy coat preparation. Parasites can also be isolated by direct
culturing of blood on NNN medium (Novy, MacNeal, Nicolle’s medium). It may take 7 to 10
days for culture to become positive. Diagnosis may also be established by xenodiagnosis.
During acute phase, the role of serology is limited in the diagnosis as antibodies take time to
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develop and false positive results have also been known to be associated with serological tests
due to cross-reaction of antibodies to non-pathogenic Trypanosoma rangeli [8, 91]. Furthermore,
detailed examination by the ophthalmologist may aid in establishing the diagnosis. However,
accumulation of retinal pigment epithelium defects have been shown in patients with intra‐
ocular involvement of intermediate and chronic Chagas disease in Paraguay/South America,
but overall fundus examination has shown to be unobtrusive [92, 93].
Acute cases of Chagas disease are treated by nifurtimox and benznidazole. Benznidazole is
given as 5–7.5 mg/kg per day orally in two divided doses for 60 days. Nifurtimox is given as
8–10 mg/kg per day orally in three or four divided doses for 90 days [91, 94].
Within few weeks, symptoms of acute Chagas disease such as Romana’s sign fade away, but
infection persists. The average life-time risk of developing complications of chronic phase is
around 30%. It may take more than 20 years to develop chronic complications. However,
trypanocidal therapy did not significantly reduce cardiac clinical deterioration through 5 years
of follow-up as documented by randomized trial of benznidazole for chronic Chagas’ cardio‐
myopathy [95, 96].
4.4. Leishmaniasis
Leishmaniasis is caused by protozoan parasite that belongs to genus Leishmania. Humans get
infection by the bite of phlebotomine sand flies. There are different clinical forms of leishma‐
niasis, such as visceral leishmaniasis (VL), cutaneous, diffuse cutaneous and mucocutaneous
caused by different species of Leishmania. Worldwide, approximately 1.3 million new cases
Figure 5. Life cycle of Trypanosoma cruzi (Diagrammatic representation).
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occur every year with a mortality of 20,000 to 30,000 persons per annum [97]. While taking the
blood meal, infected sandfly injects promastigotes into humans. Further in the human body,
the promastigotes are transformed into amastigote forms, and these are engulfed by tissue
macrophages. Amastigote forms replicate inside the cells and further spread either systemi‐
cally or through cutaneous route, depending on the species of the parasite (Figure 6). Ocular
involvement due to leishmaniasis has been reported from various countries such as India,
Sudan, Italy, Norway, Turkey and Iran (Table 1, Figure 3) [98–103]. Anterior uveitis is the most
common ocular manifestation in VL, which can occur during the course of infection and can
further progress to glaucoma [104, 105]. Focal retinal whitening, cotton wool spots, hemor‐
rhages and increased vessel tortuosity have also been reported on fundus examination [106–
110]. In severe cases, flame-shaped lesions also appear, which denote hemorrhage from the
anterior capillaries of the nerve fiber layer. These findings have also been correlated with
anemia and thrombocytopenia as these hemorrhages usually get resolved with treatment,
leading to improvement in anemia/thrombocytopenia. Optic neuropathy has been reported
due to mucosal leishmaniasis. Eyelid involvement has been documented in cutaneous and
mucocutaneous leishmaniasis [111, 112]. Severe involvement can progress to ptosis and
ectropion secondary to cutaneous leishmaniasis leading to keratopathy and altered vision
[112]. However, eyelid is rarely involved by leishmaniasis and is reported in approximately
only 2.5% of cases with cutaneous leishmaniasis [113]. The most common aspect of eyelid
leishmaniasis is chalazion-like lesions, but other forms such as ulcerous, phagedenic, cancer-
like forms and unilateral chronic granulomatous blepharitis may be observed. Chronic
dacryocystitis has been reported in patients suffering from mucocutaneous leishmaniasis,
which can effect formation of tear film, leading to dryness of eyes [114]. Endo-ocular lesions
have been observed in patients having disseminated cutaneous leishmaniasis. A report from
Brazil documented the presence of Leishmania in the aqueous humor along with iridiocyclitis
[115]. Although ocular manifestations are not very common, it is suggested that a person with
ocular manifestation from endemic country should undergo fundus examination for early
diagnosis [116].
Diagnosis of leishmaniasis can be achieved by the direct demonstration of parasites in the
tissue smears and/or biopsy samples, culture technique(s), antigen and/or antibody detection
and molecular technique(s). However, each technique has its own merits and demerits.
Amastigotes can be easily identified in the cutaneous and mucocutaneous lesions but are not
easily identified in cases with ocular disease [103, 117, 118]. Molecular techniques such as PCR/
real-time PCR can identify the genome of parasite with greater sensitivity (100%) and specif‐
icity (100%) [119, 120]. The treatment of leishmaniasis depends on several factors such as
clinical form of the disease. The antileishmanial drugs include pentavalent antimony, sodium
stibogluconate, liposomal Amphotericin B, miltefosine and paromomycin [118, 121].
Ocular lesions do not heal without treatment and could lead to vision loss if conjunctiva is
involved due to severe ulceration. Healing occurs without visual impairment if treatment is
initiated early during the course of infection and vigorous treatment is required to prevent
blindness [121, 122].
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4.5. Malaria
Malaria is caused by the parasites of Genus Plasmodium and is transmitted by the bite of female
anopheles mosquitoes. The malarial parasite passes its life cycle in humans and mosquitoes.
Inside human host, Plasmodium undergoes exoerythrocytic and erythrocytic schizogony as
shown briefly in Figure 7. Malarial parasite multiplies by asexual method (schizogony) while
residing inside liver cell and the red blood cells. After the parasites have undergone erythro‐
cytic schizogony for a certain period, some of the merozoites give rise to gametocytes, which
are taken up by mosquitoes during their blood meal. The gametocytes further develop into
sporozoites that are infective to man. Sporozoites when introduced into humans are not
directly infective for red blood cells, but undergo development initially in hepatic cells
(exoerythrocytic schizogony) and later on invade red blood cells to complete erythrocytic
schizogony. As per World Malaria Report 2014 [123], an estimated 3.3 billion people are at risk
of developing malaria (Table 1, Figure 3). Complications of severe malaria due to P. falcipa‐
rum mainly occur due to the sequestration of malarial parasite in the microvasculature leading
to occlusion and hypoxia. Most of the ocular manifestations occurring in malaria are a result
of the same mechanism. Sequestration is further amplified by auto agglutination and resetting
[124, 125].
Figure 6. Life cycle of Leishmania (Diagrammatic representation).
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Figure 7. Life cycle of Plasmodium (Diagrammatic representation).
Wide range of ocular symptoms has been reported in patients suffering from malaria. Un‐
complicated malaria is usually not associated with significant ocular findings but rarely may
be associated with edema and hyperemia of the eyelids, chemosis of conjunctiva, conjunctival
hemorrhage and anterior uveitis [126]. On the other hand, severe ocular manifestations may
occur in cerebral malaria due to P. falciparum leading to visual field defects, cortical blindness,
optic neuritis, papilledema and optic atrophy [127]. Ocular motor disturbances have also been
reported. Occasionally, infarcts in brainstem may cause changes in pupillary reaction and
disorders of eye movements. Patients with cerebellar syndromes may present as nystagmus
[128, 129]. Characteristics features such as retinal whitening consisting of irregular patchy
areas may be localized or diffused in all segments of retina [130]. Blood vessel changes manifest
as discoloration (white or orange) occurring mainly in the peripheral fundus, whereas white-
centered retinal hemorrhages may manifest as malaria retinopathy. Discoloration of retinal
vessels occurs due to the absence of hemoglobin in parasitized erythrocytes, sequestered
within retinal vasculature and thus cannot reflect normal red color. Retinal changes in cerebral
malaria are considered as poor prognostic markers [131]. The prevalence of any retinopathy,
papilledema, hemorrhages, vessel changes, macular whitening and peripheral whitening has
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been reported in 61, 15, 46, 32, 46 and 44%, respectively, among children with cerebral malaria
in Malawi [132].
Diagnosis of malaria is established by light microscopy or by rapid antigen detection kits. Light
microscopic examination of Giemsa-stained peripheral blood smear is considered as gold
standard for the diagnosis of malaria with a threshold of about 50–100 parasites/µL [133].
However, in addition, ocular examination may provide clue to the diagnosis as specific retinal
changes can be seen directly [129, 134, 135].
Treatment depends on the species of Plasmodium causing infection. Artemisinin combination
therapy is recommended for malaria due to P. falciparum. Artemisinin combination therapy
includes short-acting artemisinin derivative and long-acting antimalarial (sulphadoxine-
pyrimethamine, lumefantrine). Chloroquine along with primaquine is recommended for
malaria due to P. vivax. Ocular toxicity [136] is very well documented with chloroquine
therapy. This includes corneal changes (cornea verticillata) and corneal deposits. Toxic
maculopathy and scotoma has also been reported. Quinine overdose has also been known to
cause decreased vision, retinal and macular degeneration, mild scotomas and color vision
defects [136].
If not treated, malarial retinopathy is associated with serious consequences as reports indicate
that the severity of retinopathy is related to prolonged death and coma. After antimalarial
treatment and resolution of coma in severe malaria, malarial retinopathy resolves after some
time [132, 137].
4.6. Microsporidiosis
Microsporidiosis is the term used to denote the infection caused by microsporidia belonging
to phylum Microspora [23]. Microsporidia were once thought to be protists but are now known
to be fungi. Although it is classified as a protozoal disease in ICD-10, their phylogenetic
placement has been resolved to be within the fungi [138]. Microsporidiosis is considered as an
opportunistic infection in AIDS/HIV-infected individuals and is prevalent worldwide (Table
1) [1]. Microsporidia are small, unicellular, spore forming, obligate intracellular pathogens.
Important genera responsible for ocular manifestations are Encephalitozoon and Nosema.
Another species, Septata, has also been reported to cause keratoconjunctivitis [139]. The
prevalence of microsporidiosis ranges from 2 to 50% among severely immunocompromised,
HIV-infected patients found in North America, western Europe and Australia. The prevalence
data for microsporidiosis is limited among non-HIV-infected persons [9].
1. The life cycle of parasite involves three stages (Figure 8):
2. The resistant spore (infective form)
3. The spore injects the infective sporoplasm into the host cell. Inside the host cell, sporo‐
plasm undergoes multiplication either in the cell cytoplasm or inside parasitophorous
vacuole. Microsporidia develop to mature spores by sporogony that are released by
disruption of cell membrane. The free mature spores are the infective forms.
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Figure 8. Life cycle of Microsporidia (Diagrammatic representation).
Ocular manifestations caused by Microsporidia are mainly limited to conjunctiva and cornea.
Corneal involvement may lead to punctate epithelial keratitis, hyphema, necrotizing keratitis
and corneal ulcer. Symptoms include foreign body sensation, photophobia and decrease in
visual acuity [23].
Diagnosis is established by direct demonstration of the spores by microscopy or electron
microscopy of the corneal scrapping or biopsy specimens. Isolation of the parasites in culture
has also been attempted [140]. There are no reports on use of serological tests to detect
antibodies in serum or tears in ocular microsporidiosis [9]. Lesions usually heal after 1–2 weeks
as it is self-limiting. Treatment of microsporidial keratoconjunctivitis with polyhexamethylene
biguanide does not offer any significant advantage but treatment with topical fumagillin
showed significant improvement [141–143].
4.7. Giardiasis
Giardiasis is caused by Giardia duodenalis (syn. G. lamblia or G. intestinalis) [144]. The infection
is transmitted by ingestion of contaminated water/food or directly by feco-oral route. The
parasite exists in trophozoite and cyst forms as shown in Figure 9. In the trophozoite stage the
parasite multiplies in the intestine of man by binary fission. When conditions become unfav‐
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orable in the small intestine, encystment occurs and cysts are released along with feces. After
ingestion, within 30 minutes, cyst hatches out trophozoites that further multiply in the small
intestine. It is found both in developing and developed nations (Table 1, Figure 3). Although
it mainly causes diarrhea and malabsorption, in one-third of the patients, it can also result in
long-term extra intestinal manifestations [145].
Figure 9. Life cycle of Giardia lamblia (Diagrammatic representation).
Barraquer was the first to report the ocular manifestation (iridiocyclitis, choroiditis and retinal
hemorrhages) in patients who were suffering from diarrhea due to G. duodenalis. Retinal
changes in the form of ”salt and pepper” degeneration have been reported in children suffering
from giardiasis. Corsi et al. [146] reported salt and pepper retinal changes in 19.9% of the
patients with giardiasis. This occurs due to the damage of the retinal cells and subsequent
release of pigment granules in retina giving an appearance of blackish dots on a background
of light yellow pink retina. The exact mechanism(s) by which giardiasis leads to ocular
manifestations is still unknown, although possibility of direct invasion by the parasite is
excluded (137). Further studies are desired to exactly pinpoint the mechanism by which retinal
manifestations follow the occurrence of intestinal giardiasis. Alterations in the retinal pigment
layer are most common but do not cause functional changes in retina, and these lesions do not
progress or regress with time [146].
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The diagnosis is established by direct demonstration of the parasite in the fecal samples by
microscopy. Concentration techniques of the samples yield higher sensitivity. Nitroimidazole
group of drugs are highly effective against G. duodenalis. Most commonly used drugs are
metronidazole for 5–7 days or ornidazole/tinidazole in single dose [147]. Treatment of
intestinal infection is recommended if present, but no specific treatment is required for ocular
manifestations related to retina [146].
5. Nematode infections
5.1. Onchocerciasis
Onchocerciasis, also known as “river blindness”, is caused by Onchocerca volvulus, the filarial
nematode. It is transmitted from person-to-person by the repeated bites of infected blackflies
(Simulium species). These blackflies are mostly found near the flowing rivers and streams and
transmit the infection to the people residing in nearby remote villages [148]. The life cycle of
the parasite passes between black flies and humans as shown in Figure 10. While taking a blood
meal, stage 3 larvae present in infected blackfly are transmitted onto human skin and penetrate
into bite wound. In subcutaneous tissue, these larvae develop into adult filariae. Adult worm
produces hundreds of thousands of embryonic larvae (microfilariae) that may persist for 3-5
years in the human host. These embryonic larvae migrate to the skin, eyes and other organs.
The microfilariae are ingested by the female blackfly when it bites infected humans and
develop further in the blackfly. During subsequent bites, it transmits infection to new human
host [148, 149].
Onchocerciasis mainly occurs in tropical countries and majority of the cases (99%) have been
reported from sub-Saharan Africa. It is also found in some countries of the Middle East and
Latin America such as Brazil, Guatemala, Mexico and Venezuela (Table 1, Figure 11). Ap‐
proximately, 25 million people are known to be affected by onchocerciasis worldwide, and it
is known to cause visual impairment and blindness in approximately 800,000 and 300,000
people, respectively [148, 150]. The inflammatory response initiated against dying microfilar‐
iae causes gradual and progressive loss of vision due to sclerosal keratitis [149, 151]. Apart
from causing keratitis, clinical features may also manifest as iridiocyclitis, chorioretinitis and
optic atrophy. Autoimmune mechanisms have also been postulated to cause inflammation in
the posterior eye. Accumulation of retinal and retinoic acids, strong eosinophilic response and
immune reaction against Wolbachia antigens [152] released by dying microfilariae also
contributes to the ocular pathogenesis [153].
The filarial parasites of major medical importance in humans contain the symbiotic bacterium
Wolbachia, and reports have revealed that targeting of these bacteria with antibiotics results in
a reduction in worm viability, development, embryogenesis and survival. Wolbachia is present
as an intracellular bacteria symbiont in all the developmental stages of Onchocerca volvulus.
Clearance of the endosymbionts by antibiotic treatment causes inhibition of worm develop‐
ment. Wolbachia contributes directly to the metabolic activity of the nematode. Various
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biochemical pathways such as heme, nucleotide and enzyme co-factor biosynthesis are intact
in Wolbachia but absent or incomplete in nematode [154].
Diagnosis is difficult to establish in light infections. Skin snips can be subjected to microscopy
for visualizing the larvae, but it yields very low sensitivity. Infections of the eye can be
diagnosed with direct demonstration of the parasite by slit-lamp examination or by demon‐
strating the parasite in sclerocorneal punch biopsy. Newer techniques such as skin-snip PCR
can establish the diagnosis if larvae are not visualized [155]. Antibodies can be detected by
ELISA or EIA, but these tests cannot distinguish between past and current infections [156,
157]. Skin-snip PCR has 84–91% sensitivity and 100% specificity [149]. The sensitivity and
specificity of serum antibody detection has been reported to be 78–99% and 95–100%, respec‐
tively [149]. A promising antigen detection by dipstick assay was recently developed, but its
specificity was found to be low in high endemic areas due to cross reaction with urine filarial
antigen [158, 159]. Xenodiagnosis (exposing possible infected tissue to a vector and then
examining the vector for the presence of microorganism) has also provided clue in some cases.
If the infection is not treated on time, it can progress toward blindness [160]. Drug of choice
for the treatment is ivermectin, given 150 to 200 µg /kg body weight, every 6 months to prevent
the skin damage and blindness. Treatment with ivermectin has been shown to decrease visual
field loss and severity of keratitis. Ivermectin only kills the larvae but not the adult worms.
Doxycycline can be used to kill the adult worm. The mechanism of action is that it kills the
Figure 10. Life cycle of Onchocerca volvulus (Diagrammatic representation).
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Wolbachia bacteria residing in the worm, on which the adult worm depends for its survival.
Treatment with a 6-week course of doxycycline has been shown to kill more than 60% of adult
female worms and to sterilize 80–90% of females 20 months after treatment. Thus, treatment
with ivermectin is advised one week prior to treatment with doxycycline to provide relief to
patient [148, 161].
The best method to get the protection from insect bite is the use of insect repellent. Community-
directed treatment with ivermectin (CDTI) along with vector control measures is the main
approach to control onchocerciasis. Ivermectin kills microfilariae and also prevents adult
worms from producing more microfilariae for few months following treatment, so reduces
transmission [148].
5.2. Loiasis
Loiasis is caused by Loa loa, the African eyeworm. It is transmitted by the bite of tabanid flies,
belonging to the genus Chrysops. It affects approximately 3 million people, residing in certain
rain forests of Central and West Africa (Table 1, Figure 11) [162, 163]. The tabanid flies most
commonly bite during day time and are more common during rainy season. The smoke of
wood fires and movement of people attract them. These flies are more commonly found near
rubber plantations and are attracted by the well-lit homes. The larvae are passed from flies to
humans when humans are bitten by these flies [162]. The larvae develop into adults in the
human host over one year and migrate through cutaneous and subcutaneous tissue (Figure
12). Migration of the adult worm is painless, but it is associated with mild tingling sensation.
It may involve the nasal area, bulbar conjunctiva and eyelids [164].
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Onchocerciasis;  Loiasis   Dirofilariasis;  Gnathostomiasis;   Thelaziasis;  Toxocariasis;  Cysticercosis;             
 Echinococcosis;   
Figure 11. World map showing geographical areas endemic for ocular nematode and cestode infections.
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Figure 12. Life cycle of Loa loa (Diagrammatic representation).
Ocular manifestations may occur due to the presence of both microfilariae and adult worms.
The adult worms may survive up to 15 years and have been found in the conjunctiva, vitreous,
eyelid and anterior chamber. Calabar swellings [165] may occur as a result of localized
angioedema due to intense atopic reaction. Retinal hemorrhages may occur due to aneurysmal
dilatation of the retinal vessels due to the invasion of the retinal and choroid vessels by the
microfilariae present in blood stream. Perivascular inflammation can also be present, and
ocular examination under slit lamp examination is useful in establishing the diagnosis.
The diagnosis is usually confirmed by the direct demonstration of the microfilariae in the blood
by visualizing Giemsa-stained slides under the microscope. However, many of the individuals
having visible worm in the eye may test as amicrofilaraemic [166]. Blood should be drawn
during the midday as this time coincides with the periodicity of the microfilariae in the blood.
The microfilariae can also be demonstrated in unstained blood smear. Adult worm extraction
establishes the diagnosis in patients having conjunctival involvement [167]. Antibody detec‐
tion [168] may aid in establishing the diagnosis, but its presence cannot differentiate between
recent and past infection. Eosinophilia and high IgE also indicate active infection [169].
Eye worm if not treated causes very little damage to eye as it lasts less than one week (often
just hours). Surgical removal relieves eye symptoms, in addition medical treatment is required
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for treating loiasis [170]. Therapy involves manual removal of adult worms and administration
of diethylcarbamazine (DEC), which kills both adult worms and microfilariae.
5.3. Dirofilariasis
Dirofilariasis is caused by nematodes belonging to the genus Dirofilaria. The various species
of Dirofilaria that are natural parasites of domestic and wild animals are D. immitis, D. repens,
D. tenuis and D. ursi [37]. It is prevalent worldwide and is an important zoonotic infection. It
is being reported in increasing numbers from Mediterranean countries such as Italy and have
also been reported from France, Greece, Spain, Croatia, India, Serbia, Denmark, Russia and
Tunisia (Table 1, Figure 11). The parasite passes its life cycle in canids as definitive host as
shown in Figure 13. Mosquitoes act as intermediate host and vector for the transmission of
infection from animals to human host. Mosquitoes take up microfilariae along with blood meal
from the infected host, develop inside the mosquitoes and are subsequently transmitted to
other hosts while taking a fresh blood meal. Larvae migrate from the subcutaneous tissue to
the right side of the heart and/or to other parts of the body where maturation takes place.
Depending on the site of lodgment, it can cause pulmonary, cardiovascular, subcutaneous or
ocular infection [28].
There are several cases that document ocular involvement due to dirofilariasis [37, 171–173].
Ocular symptoms depend on the site of infection. Eyelid involvement [174] leads to edema,
Figure 13. Life cycle of Dirofilaria repens (Diagrammatic representation).
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pain, pruritus and congestion of conjunctiva, whereas intraocular [175] involvement leads to
foreign body sensation, diplopia, photophobia and floaters.
Diagnosis can be established by the direct demonstration and identification of the adult worm.
Intraocular presence of the parasite can be confirmed by ophthalmoscopy. Serological
techniques are not useful in establishing the diagnosis due to the cross reaction with other
parasitic helminths, particularly Toxocara canis. Recombinant proteins proved to exhibit 100%
sensitivity and 90% specificity by ELISA for the diagnosis of pulmonary dirofilariasis [176].
Without treatment, worm remains in eye causing symptoms due to its presence [177]. Surgical
excision is the treatment of choice; however use of diethylcarbamazine (DEC) has also been
reported with some success [37, 178].
5.4. Gnathostomiasis
Gnathostomiasis is a food-borne zoonotic parasitic infection, caused by ingestion of raw or
undercooked freshwater fish, pork, chicken, frog and snake [179, 180] contaminated with the
third-stage larvae of Gnathostoma species. The life cycle of the parasite passes in pigs, cats and
wild animals as definitive host, whereas small crustaceans act as first intermediate host and
fish, frog or snake act as second intermediate host as depicted in Figure 14. In the infected
person, larvae migrate through viscera and reach internal organs and subcutaneous tissues.
Depending on the location of lodgment, it can cause cutaneous, visceral, ocular or cerebral
gnathostomiasis. Majority of the cases have been reported from East Asia (Thailand, China,
Japan and India) and Central and South America (Mexico, Guatemala, Peru and Ecuador)
(Table 1, Figure 11). However, sporadic cases have been reported worldwide [181]. Gnathos‐
toma spinigerum is the most common species causing infection in humans.
Ocular manifestations occur due to the migration of the parasite and its metabolites, leading
to inflammatory response. Conjunctiva and corneal infection may lead to congestion of the
conjunctiva and corneal ulceration, respectively. Intraocular involvement may lead to glau‐
coma, uveitis, retinitis and vitreous hemorrhage [182, 183]. In severe cases, retinal detachment
has also been reported due to the fibrinous scarring along the migratory path.
Diagnosis is difficult to establish and high index of suspicion is required. Patients may present
with marked eosinophilia [184] and elevated IgE levels [185]. ELISA for specific antibody
detection and histopathological examination of the biopsy samples may assist in establishing
the diagnosis [186–188]. ELISA for antibody detection reported to have low sensitivity, ranging
from 59 to 87%, with a specificity of 79–96% [189, 190]. If parasite is not removed, it leads to
persistence of visual disturbances such as floaters. Surgical treatment is curative and only
modality available [191].
5.5. Thelaziasis
Thelaziasis is caused by nematode Thelazia callipaeda, transmitted to humans by drosophilid
flies [192]. It is also known as oriental eyeworm due to its geographical distribution in Asia
Pacific region (China, India, Thailand, Indonesia, Japan and Korea) and Russia [12, 193] (Table
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1, Figure 11). The life cycle passes in dogs and other canids, cattle and horses as definitive host
and flies act as intermediate host as shown in Figure 15. First-stage larvae are present in the
lacrimal secretions of infected humans/animals. The arthropod vectors while feeding on
infected lacrimal secretions ingest these larvae, which further develop into infective third-stage
larvae. The vector transmits accidentally third-stage larvae when it feeds on lacrimal secretion
of other persons/animals. Within 5–6 weeks, these larvae further develop into adult form in
the eye of an infected person. These parasites mainly cause infection of the anterior segment
of the eye, but intraocular infections involving vitreous and retina have also been reported. It
is a disease associated with poor personal hygiene.
Without treatment, worm remains in eye causing symptoms due to its presence [194]. Treat‐
ment is surgical removal of worms along with the topical application of thiabendazole.
Preventive measures include use of bed nets at night, maintenance of personal hygiene and
keeping surroundings clean to control the vector population responsible for the transmission
of infection [8].
Figure 14. Life cycle of Gnathostoma (Diagrammatic representation).
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5.6. Toxocariasis
Toxocariasis is caused by Toxocara species. Toxocara canis and T. cati are the most common
species causing toxocariasis in humans worldwide, particularly in Asia, Japan, Korea, Ireland
and Alabama [195–199] (Table 1, Figure 11). The life cycle of Toxocara involves dogs (T. canis)/
cats (T. cati) as definitive host (dog/cat). Infection is transmitted by consumption of eggs of
Toxocara parasites, passed in the feces of definitive host (dog/cat) as shown in Figure 16. After
the ingestion of eggs, larvae hatch out from the eggs in the small intestine and penetrate mucosa
to migrate to different organs such as liver, lung and trachea, leading to visceral larva migrans
(VLM). Sometimes, target larvae may migrate to eyes causing ocular larva migrans (OLM)
[200, 201]. Host immune response is weaker in ocular larva migrans than visceral larva
migrans. Various ocular clinical manifestations such as keratitis, hypopyon, iritis, uveitis,
posterior pole granuloma, vitreous abscess and retinal detachment, strabismus, vision loss are
attributed due to vitritis, cystoid macular edema and tractional retinal detachment [11, 202–
204]. Based on clinical and physical examination, ocular toxocariasis is classified as chronic
endophthalmitis, posterior granuloma and peripheral granuloma [205]. Approximately 25–
50% of ocular toxocariasis patients present as posterior pole granuloma, due to lodging of the
parasite in small perifoveal end-arteries, and approximately in 50% of ocular toxocariasis
patients peripheral granuloma is present. Acute lesion appears as hazy, white mass in the
Figure 15. Life cycle of Thelazia (Diagrammatic representation).
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peripheral fundus that may mimic the appearance of snowbank seen in patients with pars
planitis.
Figure 16. Life cycle of Toxocara (Diagrammatic representation).
High index of suspicion is required for establishing the diagnosis of OLM during ocular
examination [205]. Marked eosinophilia along with positive serology by ELISA [206] helps in
confirming the diagnosis [207]. Detection of specific antibodies in the vitreous fluid also helps
in differentiating it from retinoblastoma [208]. ELISA based on the excretory-secretory antigens
of T. canis reported to have a sensitivity of 78% [209]. ELISA developed by Seoul National
University, using crude antigen of Toxocara larvae, showed a sensitivity of 92.2% and specificity
of 86.6% [210]. PCR available in research laboratories [211] may help in the diagnosis of ocular
toxocariasis. Nucleotide homology of 97–99% has been reported between Vietnamese Toxocara
canis and other Toxocara geographical strains by comparing the nucleotide sequence of internal
transcribed spacer 2 (ITS2) of ribosomal DNA of T. canis [212]. Although PCR has been shown
to be the best diagnostic modality in animal models of ocular toxocariasis, molecular techni‐
ques are not available in hospitals of resource limiting countries [213]. Vision loss, eye
inflammation or damage to the retina occurs if not treated. Prognosis is good with medical
and surgical treatment [200].
Albendazole and mebendazole are the drugs of choices for the treatment of VLM [214, 215].
However, there is a limited role of antiparasitic drugs in the treatment of OLM. Photocoagu‐
lation along with steroids has been recommended for the treatment of OLM.
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6. Cestodes infections
6.1. Cysticercosis
Cysticercosis is caused by the larval cysts of the tapeworm Taenia solium. Humans acquire
cysticercosis infection by the consumption of food contaminated with the Taenia solium eggs,
passed in feces of the infected humans, harboring the adult worms in their intestine as depicted
in Figure 17 [216]. Autoinfection has also been reported in persons suffering from taeniasis
that may result in cysticercosis. Eating of raw or uncooked pork results in adult worm infection,
the taeniasis. It is considered as one of the important neglected parasitic infections (NPIs),
prevalent in Asia, Africa and Latin America where poor sanitation conditions prevail (Figure
11) [217]. These larval cyst may lodge into different organs/tissues (brain, muscles, eyes or
other tissues) [218], resulting in varying clinical symptoms.
Ocular involvement is well documented and several case reports have documented the orbital,
intraocular, subretinal and optic nerve involvement due to cysticercosis [219, 220]. Free-
floating cyst can be found in vitreous or anterior chamber of the eye. Cranial nerve or intra‐
ocular muscles lesions may result in gaze palsies [221–223].
Diagnosis is usually established by ophthalmoscopic examination along with imaging
evidence of ultrasonography, CT scan or MRI scan. Although serology is easy to perform, it is
usually negative in isolated ocular cysticercosis patient [224]. Molecular techniques such as
Figure 17. Life cycle of Taenia solium (Diagrammatic representation).
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conventional PCR, real-time PCR [218] and loop-mediated isothermal amplification (LAMP)
[225] can be utilized for establishing the diagnosis of ocular cysticercosis and for genotyping
[30, 226]. However, it requires a sophisticated molecular laboratory setup, which is not
available widely in developing nations.
Without treatment, symptoms related to visual disturbances persist. Symptoms resolve with
surgical and medical treatment [227]. Albendazole along with steroids are the main drugs used
in the treatment. Steroid treatment decreases the inflammatory response associated with the
antihelminthic therapy around the lesions. Surgical removal of large cysts is recommended
where there is an impairment of the vision [224].
6.2. Echinococcosis
Echinococcosis/hydatidosis is caused by infection of the larval stages of the Echinococcus spp
[228], and ocular manifestations occur approximately in 1% of the cases suffering from hydatid
disease [229]. Echinococcosis is mainly found in Asia, Africa, Latin America, Russia, Australia
and the Mediterranean regions (Figure 11) [230]. It is acquired by the consumption of conta‐
minated food and water with fecal matter containing eggs of Echinococcus parasites. The life
cycle includes development of adult worms in small bowel of definitive hosts such as dogs
and other canids. Eggs are passed in feces and contaminate environment as shown in Figure 18.
Figure 18. Life cycle of Echinococcus (Diagrammatic representation).
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The symptoms and signs depend on the location of the cyst in the target organ. Most common
ocular finding is the development of proptosis due to the presence of intraorbital space
occupying lesion. This may further lead to exposure to keratitis and ulceration of the cornea.
Other complications due to the local invasion of the expanding cyst may lead to erosion of
orbital wall, optic atrophy and optic neuritis. Subretinal hydatid cyst has been reported. In
severe cases, blindness may also occur [231].
The diagnosis depends on the clinical findings suggestive of hydatid cyst on ocular examina‐
tion and confirmed by radiological techniques such as ultrasonography, CT scan and/or MRI
[232, 233]. “Double wall” sign is a characteristic of orbital hydatid cyst seen by ultrasonography
[232]. Serology may also aid in diagnosis. However, in majority of the commercially and in-
house serological assays, hydatid fluid is the main antigenic component and sensitivity of IgG-
ELISA reported in various studies varies from 64.8 to 100%, while specificity varies from 87.5
to 100%. Purified and recombinant antigens are also being tried for developing ELISA with
high sensitivity and specificity [234]. Fine needle aspiration cytology can also be performed
for establishing the diagnosis [235].
Symptoms persist if not treated [236]. Surgical removal of the cyst is the treatment of choice.
Medical therapy includes administration of albendazole or mebendazole to prevent the
recurrences due to the contents of the cyst leaking into the surgical sites [237]. If the cyst is
accidently ruptured, in situ irrigation with hypertonic saline should be performed. However,
it causes local inflammatory reaction that may lead to atrophy of optic nerve [238].
7. Trematodes infections
7.1. Fascioliasis
Fascioliasis is a food-borne parasitic infection caused by trematodes that mainly affect liver. It
is acquired by eating metacercaria of Fasciola hepatica encysted on leaves that are eaten raw.
Two important species are Fasciola hepatica and F. gigantica. The life cycle includes release of
eggs from adult flukes that further develop into miracidia, sporocysts, rediae, cercariae and
metacercariae as shown in Figure 19. The parasite passes its life cycle in two different hosts:
sheep, goat, cattle and man act as definitive host and snails of the genus Lymnaea act as
intermediate host. The eggs are passed out in the feces of definitive hosts that mature in water.
Ciliated miracidium develops inside each egg in 2–3 weeks. Miracidium after getting released
from egg finds its way to its suitable intermediate host. Inside the lymph spaces of the
molluscan host, the miracidium passes through stages of sporocyst, two generations of rediae
and finally to the stage of cercariae. The mature cercariae escape from the snail into the water
and encyst (metacercariae) in blades of grass or water-cress, which is ingested by herbivorous
animals and occasionally by man. On entering the digestive tract, the metacercariae excyst in
the duodenum and migrate through intestinal wall into peritoneal cavity. It further traverses
through liver capsule, parenchyma and ultimately settle in the biliary passages, where it
mature into adults. The eggs are liberated in the feces through bile, completing the life cycle.
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Opthalmofascioliasis is the term used for those cases in which eye infection is directly caused
by migrant ectopic fasciolid fluke. All other patients with ocular manifestations due to
fasciolids located in liver or other organs should be classified as fascioliasis with ocular
implications. Although ocular involvement in fascioliasis is rare, cases have been reported
from France, Spain, Italy, Austria, Belgium, United Kingdom, Algeria, Tunisia, Iran, Uzbeki‐
stan, Korea, China, Argentina, Chile, Peru, Brazil and Guatemala (Figure 20) [239]. Symptoms
and signs usually relate to the affected eye and may cause conjunctival hyperaemia, corneal
oedema, dilated episcleral vessels, paralysis of extraocular muscles, decrease in perception of
light, deep anterior chamber with flare, uveitis and so on. Diagnosis is established directly by
visualization of leaf-shaped like organism in the eye or by studying the morphological features
of the surgically removed worm. Eosinophilia, positive serology by ELISA or presence of eggs
in stools may aid in diagnosis. Severe complications may occur if not treated. Early surgical
intervention is associated with rapid response and reasonable final visual acuity [14]. Thus,
ophthalmological manifestations have been known to be cured with surgical treatment
without any antiparasitic treatment [14]. However, triclabendazole is the drug of choice if
medical treatment is required.
7.2. Schistosomiasis
Schistosomiasis, or bilharziasis, is caused by trematode flatworm of the genus Schistosoma.
Freshwater snails release the larval forms in the water, which penetrate the skin of human host
Figure 19. Life cycle of Fasciola (Diagrammatic representation).
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while swimming, bathing, fishing and even domestic chores such as laundry and herding
livestock. In the human body, the larvae mature into adult schistosomes, which reside in the
blood vessels. Eggs released by females are passed out of the body in the urine or feces. It is
prevalent in sub-Saharan Africa, China and South Asia (Figure 20) [8].
Ocular involvement is not the usual site that is involved in schistosomiasis, but cases have
been reported where Schistosoma ova or even the adult worm can reach the systemic circula‐
tion and can lodge itself at ectopic sites such as eyes. Although schistosomiasis is very common,
ocular cases are rare. It can cause uveitis or subretinal granuloma [240]. Diagnosis is established
by direct demonstration of eggs/cercariae in the eye. Detection of eggs in the urine and feces
may aid in establishing the diagnosis. Symptoms persist if not treated. Praziquantel is the drug
of choice for all forms of schistosomiasis [8].
7.3. Other rare ocular infections by trematodes
The cases of acute nodular conjunctivitis and anterior chamber granuloma formation have
been  documented,  which  are  caused  by  endemic  water-borne  trematode  infection.  The
identification of  the remnants of  parasites aspirated from such cases revealed that  these
parasites belong to the genus Philophthalmus  that are known to parasitize birds [25, 241].
Humans  acquire  infection  accidently  while  bathing  or  playing  in  contaminated  water.
Conjunctival nodules heal spontaneously, and anterior chamber nodules can be treated with
topical/oral corticosteroids. Surgical removal is recommended in cases having large nod‐
ules. First human case of Clinostomum lacramalitis was reported in Thailand [242]. Human
cases  of  intraocular  infection  with  mesocercariae  of  Alaria  americana  and  other  Alaria
mesocercariae have been reported in patients who had ingested undercooked contaminat‐
ed frogs legs [243].
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Fascioliasis;  Schistosomiasis;    Philopthalmosis;    Clinostomum lacramalitis;   Alaria mesocercariasis 
Figure 20. World map showing geographical areas endemic for ocular trematode infections.
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8. Eye infections caused by ectoparasites
8.1. Myiasis
Myiasis is an infection caused by larvae of flies. It is common in tropical and subtropical areas.
It is known as ophthalmomyiasis when ocular structures are involved. Ophthalmomyiasis is
categorized into three clinical categories (ophthalmomyiasis externa, ophthalmomyiasis
interna and orbital myiasis), depending on the location of larvae in the eyes. Several genera
have been reported to cause myiasis such as Dermatobia, Gasterophilus, Oestra, Cordylobia,
Chrysomyia, Wohlfahrtia, Cochliomyia and Hypoderma [1]. Significantly, larvae causing ophthal‐
momyiasis belong to the genus Hypoderma [16]. Three cases of external ophthalmomyiasis, two
due to Oestrus ovis and one due to Cochliomyia hominivorax were reported earlier from North
India [17]. Oestra ovis also known as sheep nasal botfly is responsible for causing ophthalmo‐
myiasis externa in shepherding areas [244–247]. It mainly involves eyelids, conjunctiva,
lacrimal sac and nasolacrimal ducts. Most common clinical feature is the foreign body
sensation and may be associated with conjunctivitis and keratitis.
Diagnosis is established by the identification of the maggots. Treatment usually involves the
surgical removal of the maggots. Medical treatment involves just one oral dose (150 to 200 µg/
kg of body weight) of ivermectin [16]. However, the use of ivermectin for the treatment of
myiasis is an off-label treatment in many countries and should be used for selected cases. The
side effects such as dermal eruptions, fever, dizziness, migraines and muscular pains are
common. Antibiotics and steroids may also be required to prevent the inflammation and
superadded bacterial infection. Opthalmomyiasis interna [248] is caused by the invasion of the
ocular structures leading to uveitis, lens dislocation and retinal detachment. Diagnosis is
established by visualizing the migratory tracks along subretina by the ophthalmoscopy.
Symptoms persist if not treated. Serious complications may also occur such as lens dislocation
and retinal detachment due to invasion of tissue [1]. Steroid therapy is advocated if there is
severe inflammation, and surgical removal is performed in severe cases. Orbital myiasis is seen
in patients who are not able to maintain good personal hygiene [16]. Treatment is directed at
removal of maggots and control of secondary infection. Preventive measures include mainte‐
nance of good sanitation conditions and proper disposal of waste material to control the flies
in surrounding areas.
8.2. Lice
Important genera of the lice causing human infestation belong to Pediculus and Phthirus.
Geographical areas where Phthiriasis palpebrarum is commonly found have been depicted in
Table 1 and Figure 21. Eggs or nits laid down by lice glue themselves to body hairs or clothing
fibers. Nymphs emerge from eggs and feed on the host, causing pruritis. Eyebrows and
eyelashes are most commonly, involved. Excoriation marks along with small erythematous
papules aid in diagnosis. Nits can be found at the base of eyelashes, substantiating the clinical
diagnosis. Symptoms persist if not treated. Eyelid disease is treated by petrolatum and non-
eyelid involvement may be treated with lindane, permethrin, pyrethrin or malathion [1].
Ocular Parasitic Infections – An Overview
http://dx.doi.org/10.5772/64137
75
8.3. Ticks
Ticks belonging to the class Arachnida are important vectors for the transmission of several
infections to humans [1]. Geographical regions where ticks’ infestation has been reported are
depicted in Table 1 and Figure 21. Ticks complete their life cycle in three different stages, i.e.
larva, nymph and adult, and all the life cycle stages require blood meals. Ticks have been
reported to attach to ocular structures that may appear as meibomian gland mass. Symptoms
persist if not treated. Treatment includes removal of ticks, and tick bite granuloma may resolve
after several weeks.
9. Summary
Ocular parasitic infections are of medical importance worldwide because of significant
morbidity rates, and if not diagnosed and treated on time could lead to vision loss. High index
of clinical suspicion is required to establish the diagnosis for further confirmation by laboratory
techniques followed by specific treatment. Direct demonstration of the parasite is possible in
few ocular parasitic infections, while in few, specific clinical features such as changes in retina
on direct ocular examination may point toward specific diagnosis. Serology has limited role
in the diagnosis as most of the ocular parasitic infections are localized in the eye. Utility of
different diagnostic techniques in various parasitic ocular infections has been summarized in
Table 2. Although reports reveal that the serology for antibody detection and/or molecular
techniques for parasite DNA detection, when applied directly on the ocular tissues, aqueous
 Phthiriasis palpebrum;       Tick infestation. 
Figure 21. World map showing geographical areas endemic for ocular ectoparasites. Phthiriasis palpebrarum; Tick infes‐
tation.
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or vitreous humor usually confirm the diagnosis, these techniques have its own merits and
demerits. IgG immunoblot technique has been applied for the diagnosis of ocular toxoplas‐
mosis with some success, and it is suggested that local antibody production is presumed to
have occurred, if immunoreactive bands are detected in the aqueous humor but not in the
serum [249]. Future reports in this direction may throw further light on its utility. Moreover,
application of Western blotting technique may be possible only in limited diagnostic centers.
Report on “Diagnostic Approach to Ocular Toxoplasmosis” revealed in conclusion that the
clinical diagnosis of ocular toxoplasmosis may be supported by laboratory tests in 60–85% of
cases, depending on the time of sampling. Analysis of the aqueous humor is particularly
helpful in patients with atypical lesions or in individuals who are irresponsive to specific
therapy. Even so, a laboratory confirmation of the clinical diagnosis is not achieved in 15–40%
of cases [72].
In general, it can be concluded that the clinical awareness and multiple approaches/techniques
for the confirmatory diagnosis of clinically suspected ocular parasitic infections may yield
higher sensitivity and diagnostic efficacy, as suggested earlier [250].
Treatment depends on the causative agent and may involve surgical removal and/or medical
treatment with antiparasitic drugs (Table 2). In few infections, steroids are also prescribed to
prevent the damage from the inflammatory response associated with the dying parasites.
Preventive strategies depend on the type of parasitic infection and mainly include control of
vector population for vector borne parasitic infections, maintenance of good personal hygiene
and providing awareness to people about ocular parasitic infections through information,
education and communication (IEC).
The need of increased awareness and clinical suspicion of OPI for prompt and specific
diagnosis followed by application of sensitive and specific diagnostic technique(s) for confir‐
mation and effective treatment are the main challenges.
The future research priorities need to be directed to study exact host-pathogen mechanisms,
local immune responses and to establish more sensitive and specific diagnostic techniques.
The molecular techniques can provide rapid diagnosis of multiple ocular parasitic infections
and species identification for specific therapy. Multiplex PCR assay, if developed, can add new
dimensions in the diagnosis. Efforts to develop animal models are desired that may further
help to study the exact host-pathogen mechanisms, local immune responses and in developing
new treatment strategies.
Ocular protozoal
infections
Diagnosis Treatment
Toxoplasmosis Serology – IgM, IgG, IgA
Molecular: PCR, Real-time PCR
a. Pyrimethamine and sulfadiazine plus corticosteroids
b. Trimethoprim/sulfamethoxazole plus oral prednisolone
c. Intravitreal clindamycin (1-1.5mg) injection and
dexamethasone
d. Surgery reserved for severe complicated cases
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Ocular protozoal
infections
Diagnosis Treatment
Acanthamoeba keratitis Microscopy, culture on non-
nutrient plates (coated with
bacteria)/ in flasks (PBS
+Bacteria), PCR, Real-time PCR
a. Biguanides – PHMB (0.02%)
b. Chlorhexidine 0.02% in combination with aromatic
diamidines such as 0.1% propamidine isethionate, 0.15%
dibromopropamidine, hexamidine 0.1% and neomycin
(Topical antimicrobials should be administered every
hourly for first several days and there after frequency
reduced to every 3 hours with a minimum duration of
therapy of 3-4 weeks
c. Surgical treatment includes keratoplasty or its variation
known as DALK (Deep Anterior Lamellar Keratoplasty)
Chagas disease Blood smear, Buffy coat, culture,
xenodiagnoses and PCR
a. Benznidazole 5-10 mg/kg daily in 2-3 divided doses for
60 days
b. Nifurtimox 15 mg/kg daily in 3 divided doses for 60-90
days
Malaria Thin and thick blood film for
microscopy, antigen detection,
PCR
a. Plasmodium vivax – Chloroquine + primaquine
b. P. falciparum – Artemisinin combination therapy
(Artemisinin + sulfadoxine-pyrimethamine or artemisinin
+ lumefantrine) as per WHO guidelines
Leishmaniasis Microscopy of tissue smears,
culture on NNN media, PCR
Pentavalent antimonial compounds, liposomal
amphotericin B, miltefosine (dose is weight dependent),
paromomycin, azoles such as ketoconazole, itraconazole
and fluconazole
Microsporidiosis Microscopy,
Immunofluorescence assay, PCR
Topical fumagillin bicylohexylammonium (Fumidil B) 3
mg/mL in saline (fumagillin 70 µg/mL) eye drops: two
drops every 2 hours for 4 days, then two drops four times
daily (investigational use only in United States) plus
albendazole 400 mg orally twice daily for management of
systemic infection.
Giardiasis Confirming by intestinal
infection
Metronidazole, tinidazole, and nitazoxanide. Others
include paromomycin, quinacrine, and furazolidone
Ocular nematode
infections
Onchocerciasis Slit-lamp examination, Biopsy of
skin to identify larvae, skin
nodules examination for
identification of adult worms,
PCR, antibody detection
a. Ivermectin: given every 6 months for the life span of the
adult worm or as long as infected person has evidence of
skin or eye infection
b. New treatment: Doxycycline, before starting treatment
infection with Loa loa has to be ruled out
c. Removal of adult worms
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Ocular protozoal
infections
Diagnosis Treatment
Loiasis a. Surgical removal of the worm under the skin or across
the eye
b. Diethylcarbamazine (DEC) is the drug of choice
c. Albendazole is given to patients not responding to DEC
Dirofilariasis a. Surgical removal of the worm
b. DEC is given for medical treatment
Gnathostomiasis Identification of the removed
worm
Serology to detect antibodies
a. Surgical removal of worm
Thelaziasis b. Identification of worm
removed from conjunctival sac
c. Eggs and larvae may be seen
by microscopy of tears and other
eye secretions
Removal of worm
Toxocariasis Histological demonstration of
toxocara larva
Serology by ELISA
d. Topical and systemic corticosteroids are useful in
managing intraocular inflammation
e. Role of anthelmintic therapy in ocular toxocariasis
remains unclear
f. Recommended drugs for systemic toxocariasis are:
g. Albendazole 400mg given twice daily for 7-14 days
h. Diethylcarbamazine - given at 3-4 mg/kg/day for 21
days
Ocular cestode infections
Cysticercosis Imaging with MRI, CT scan and
USG
Serology
a. Antiparasitic drugs – Albendazole 15mg/kg/day for 4
weeks, Praziquantel
b. Corticosteroids in tapering dose over a period of 1
month
c. Surgery
Echinococcosis Imaging a. Surgical removal
b. Albendazole is given as an anti-infective prophylaxis
Ocular trematode
infections
Fascioliasis Detection of adult worm in the
eye
Other features such as
eosinophilia, stool examination
and serology may help
a. Surgical removal of worm
b. Triclabendazole 10mg/kg body weight as a single dose
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Ocular protozoal
infections
Diagnosis Treatment
Schistosomiasis Stool and urine examination for
detection of parasitic eggs or
detection of eggs or cercariae in
eye
Serology
Praziquantel 40-60mg/kg per day in two to three divided
doses for one day
Philopthalmosis Identification of the remnants of
parasites aspirated from such
cases
a. Conjunctival nodules heal spontaneously and anterior
chamber nodules can be treated with topical/ oral
corticosteroids.
b. Surgical removal is recommended in cases having large
nodules
Ocular infections by
ectoparasites
Myiasis a. Identification of the maggots
b. Visualizing the migratory
tracks along sub retina
a. Surgical removal of the maggots
b. Ivermectin 150-200 µg/kg of body weight in single dose
c. Steroid therapy
Phthiriasis palpebrum a. Excoriation marks along with
small erythematous papules
b. Nits can be found at the base
of eyelashes
a. Eyelid disease is treated by petrolatum
b. Non-eyelid involvement may be treated with lindane,
permethrin, pyrethin or malathion
Tick infestation Biomicroscopy may reveal ticks Removal of ticks
Table 2. Diagnosis and treatment of various ocular parasitic infections
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